Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc., the developer of the first rechargeable Sacral Neuromodulation (r-SNM™) System for the treatment of urinary and fecal ...

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral ...

Axonics Modulation Technologies (AXNX – Research Report) received a Hold rating and price target from Wolfe Research analyst Michael Polark yesterday. The company’s shares closed yesterday at $69.36.

In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Hold rating to Axonics Modulation Technologies (AXNX – Research Report), with a price target of $71.00. The company’s shares ...

Axonics Modulation Technologies (AXNX) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $0.54 per share a year ago.

Axonics Modulation Technologies Inc., of Irvine, Calif., reported revenue of $1.3 million for the third quarter of 2019, up from $0.2 million in the same period last year, but below Wall Street's ...

Thank you, operator, and thanks everyone for joining the Axonics quarterly results and update call. I'm thrilled to have recently joined Axonics as Vice President of Investor Relations. Presenting on ...

* AXONICS MODULATION TECHNOLOGIES INC - MOST EMPLOYEES WILL BE TAKING TEMPORARY 20% CUT IN BASE SALARY FOR REMAINDER OF Q2 2020 DUE TO COVID-19 IMPACT Sign up here. * AXONICS MODULATION TECHNOLOGIES - ...